Artia Global Partners LP bought a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up approximately 0.1% of […]
Artia Global Partners LP acquired a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up 0.1% of Artia Global Partners LP’s holdings, making the stock its 25th largest holding. Other large […]
Swiss National Bank bought a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 33,000 shares of the company’s stock, valued at approximately $922,000. Swiss National Bank owned approximately 0.07% of […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) – Investment analysts at Wedbush raised their Q2 2024 earnings per share (EPS) estimates for shares of Apogee Therapeutics in a research report issued to clients and investors on Monday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.59) […]
New York State Common Retirement Fund boosted its position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 113.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,969 shares of the company’s stock after purchasing an additional 4,764 shares during the quarter. New York State Common Retirement Fund’s holdings in Apogee Therapeutics […]